Provided by Tiger Fintech (Singapore) Pte. Ltd.

COLLPLANT BIOTECHNOLOGIES LTD

2.02
-0.1200-5.61%
Volume:4.90K
Turnover:10.19K
Market Cap:25.69M
PE:-1.79
High:2.11
Open:2.10
Low:2.02
Close:2.14
52wk High:4.98
52wk Low:1.31
Shares:12.72M
Float Shares:8.91M
Volume Ratio:0.84
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1257
EPS(LYR):-1.4500
ROE:-78.25%
ROA:-37.90%
PB:2.05
PE(LYR):-1.39

Loading ...

Collplant Biotechnologies Ltd. to Release Third Quarter 2025 Financial Results

Reuters
·
Nov 18

Collplant Biotechnologies Ltd expected to post earnings of 16 cents a share - Earnings Preview

Reuters
·
Nov 01

CollPlant expands rhCollagen capabilities in U.S., Canada

TIPRANKS
·
Oct 27

Collplant Biotechnologies Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Oct 20

Mayo Clinic Researchers Develop First Fully Humanized 3D Bioprinted Skin Model Using CollPlant's Plant-Derived rhCollagen

Reuters
·
Oct 16

CollPlant Biotechnologies Announces Positive Preclinical Results for Novel Photocurable Regenerative Dermal Filler, Paving Way for Clinical Trials

Reuters
·
Sep 30

Collplant Biotechnologies Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Sep 16

CollPlant Biotechnologies Expands Vergenix™ STR Distribution in Europe with New Polish Agreement

Reuters
·
Sep 15

CollPlant Biotechnologies Ltd. Successfully Transfers Listing to Nasdaq Capital Market

Reuters
·
Sep 13

CollPlant Biotechnologies Ltd. to Participate in 27th Annual H.C. Wainwright Global Investment Conference

Reuters
·
Aug 25

Collplant Biotechnologies Ltd reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 20

Collplant Biotechnologies Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Aug 20

CollPlant Biotechnologies Reports H1 2025 Revenue Surge to $2.2M Despite Q2 Drop; Net Loss Narrows to $4.8M, EPS Improves to $0.41

Reuters
·
Aug 20

Press Release: COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Dow Jones
·
Aug 20

Collplant Biotechnologies Ltd expected to post a loss of 14 cents a share - Earnings Preview

Reuters
·
Aug 18

Collplant Biotechnologies Ltd. to Release Second Quarter Financial Results

Reuters
·
Aug 05

Collplant Biotechnologies Ltd expected to post a loss of 14 cents a share - Earnings Preview

Reuters
·
Jul 29

Collplant Biotechnologies Ltd expected to post a loss of 14 cents a share - Earnings Preview

Reuters
·
Jul 15

CollPlant Biotechnologies Appoints Bowman Bagley as VP of North America Commercial Operations to Drive Growth and Expansion

Reuters
·
Jul 14

Press Release: CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations

Dow Jones
·
Jul 14